Granite Point Capital Management, L.P. Immunome Inc. Transaction History
Granite Point Capital Management, L.P.
- $0
- Q3 2023
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
108Shares Held
32.2MCall Options Held
46.1KPut Options Held
32.5K-
Redmile Group, LLC San Francisco, CA4.89MShares$65.1 Million4.76% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$51.6 Million2.73% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.25MShares$29.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.02MShares$26.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.64MShares$21.9 Million0.1% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $161M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...